These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2647995)

  • 21. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
    Smaglia RA; Parkinson DR; Taylor CD
    Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
    Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
    Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Carides G; Elmer M; Schmidt C; Evans JK; Horgan KJ
    J Clin Oncol; 2003 Nov; 21(22):4105-11. PubMed ID: 14559891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.
    Bishop JF; Matthews JP; Wolf MM; Oliver IN; Reynolds S; Walpole E; Rischin D; Buchanan L; Tan LG
    Eur J Cancer; 1992; 28(1):47-50. PubMed ID: 1567690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
    Culine S; Azab M; Pietri F; Ghosn M; Ben Amor B; Lupera H; Theodore C; Renaux J; Droz JP
    Bull Cancer; 1989; 76(6):583-9. PubMed ID: 2673437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer.
    Silvey L; Carpenter JT; Wheeler RH; Lee J; Conolley C
    J Clin Oncol; 1988 Sep; 6(9):1397-400. PubMed ID: 3047334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
    Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
    Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
    J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
    Bishop JF; Olver IN; Wolf MM; Matthews JP; Long M; Bingham J; Hillcoat BL; Cooper IA
    J Clin Oncol; 1984 Jun; 2(6):691-5. PubMed ID: 6374058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy.
    Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z
    Oncology; 1989; 46(2):105-8. PubMed ID: 2652018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
    Cognetti F; Carlini P; Pinnarò P; Ruggeri EM; Caporali C
    Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
    Orr LE; McKernan JF
    J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis.
    Akhtar SS; Bano ZA; Bhat GM; Bhat MA
    Oncology; 1991; 48(3):226-9. PubMed ID: 2023702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiemetic efficacy of high-dose dexamethasone versus placebo in patients receiving cisplatin-based chemotherapy: a randomized double-blind controlled clinical trial.
    D'Olimpio JT; Camacho F; Chandra P; Lesser M; Maldonado M; Wollner D; Wiernik PH
    J Clin Oncol; 1985 Aug; 3(8):1133-5. PubMed ID: 4040553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
    Einhorn LH; Nagy C; Furnas B; Williams SD
    J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of a five-drug antiemetic combination during chemotherapy regimens containing cisplatin or cyclophosphamide-doxorubicin.
    Aydiner A; Onat H; Oztürk N; Aykan F; Inanc S; Topuz E; Dincol K
    J Pain Symptom Manage; 1993 Apr; 8(3):126-31. PubMed ID: 8326162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.